The Promising Future of Clinical Development in San Diego
SABPA Science and Technology Forum XII
Co-organized with UCSD Moores Cancer Center
Date：March 29, 2014（Saturday）, 8:30am to 1:00pm（Breakfast and lunch will be provided.）
Location：Institute of Americas, UCSD, 10111 North Torrey Pines Road, La Jolla, CA 92037
$20 for online registration（by March 27, 2014）, $10 for students and post-docs, $40 for on-site registration
San Diego is a vibrant and successful biotech hub consisting of over 400 biotech/pharma companies and a cluster of world-renowned academic research institutions. From Rituximab, a biologic drug approved over a decade ago, to the most recent Crizotinib, a small molecule drug, biotech/pharma companies in San Diego are continuing to produce innovative medicines to treat patients with cancer, diabetes, inflammation and other diseases. While strong in its biotech/pharma R&D functions, San Diego is emerging as a center for clinical trials, an essential part of the drug development process. Furthermore, as clinical trials have become increasingly more global oriented, San Diego is poised to take a leadership role in conducting international clinical collaborations, particularly with Asian Pacific countries.
At the SABPA Science & Technology Forum XII, we bring together leaders in academic and pharma/biotech industry to discuss how to move drugs quickly and efficiently to patients. Speakers from Moores cancer center and pharma companies will present their visions and efforts to strengthen the clinical trial capability in San Diego to better serve the need of local biotech/pharma community and to make San Diego a designated center for personalized cancer therapy. Speakers from leading clinical centers in China will provide their insights in how biotech/pharma companies in San Diego can leverage the emerging and rapidly growing clinical market in China to accelerate the clinical development processes.
- Scott M. Lippman, M.D.
Professor of Medicine, Director, UCSD Moores Cancer Center
- Razelle Kurzrock, M.D.
Professor of Medicine, Director, Division of Clinical Science, UCSD Moores Cancer Center
- Andreas Koester, M.D., Ph.D.
VP of Clinical Trial Innovation & External Alliances. Janssen, Pharmaceutical Companies of Johnson & Johnson
- Steffan Ho, M.D., Ph.D.
Senior Director, Early Development and Translational Oncology, Pfizer
- Eric Groves, M.D., Ph.D.
VP, Global Strategic Drug Development Innovation at Quintiles
- Dan Zhang, Ph.D.
CEO, Fountain Medical Development Ltd.
- Ida Deichaite, Ph.D.
Director of Industry Relations, UCSD Moores Cancer Center